Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Free Cash Flow Generation Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥35.19 Million represents 1% of operating cash flow (CN¥44.34 Million). See 605199 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hainan Huluwa Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Hainan Huluwa Pharmaceutical Group Co Ltd across 9 annual periods. Explore debt repayment capacity of Hainan Huluwa Pharmaceutical Group Co Lt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Hainan Huluwa Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market value of Hainan Huluwa Pharmaceutical Group Co Lt.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥53.18 Million | CN¥136.85 Million | CN¥83.67 Million | ▲ +102.4% |
| 2023 | -16.32x | CN¥-460.95 Million | CN¥28.25 Million | CN¥489.20 Million | ▼ -2435.4% |
| 2022 | -0.64x | CN¥-153.61 Million | CN¥238.71 Million | CN¥392.32 Million | ▼ -87.7% |
| 2021 | -0.34x | CN¥-35.14 Million | CN¥102.48 Million | CN¥137.62 Million | ▲ +98.0% |
| 2020 | -17.01x | CN¥-56.12 Million | CN¥3.30 Million | CN¥59.42 Million | ▼ -2953.6% |
| 2019 | 0.60x | CN¥86.12 Million | CN¥144.51 Million | CN¥58.40 Million | ▲ +146.2% |
| 2018 | -1.29x | CN¥-41.02 Million | CN¥31.80 Million | CN¥72.82 Million | ▼ -71.6% |
| 2017 | -0.75x | CN¥-67.62 Million | CN¥89.96 Million | CN¥157.58 Million | ▼ -303.6% |
| 2016 | 0.37x | CN¥23.98 Million | CN¥64.96 Million | CN¥40.99 Million | — |